MYCR

Mycronic

Market Cap 8,837.0M

The Mid Cap company Mycronic develop systems for electronics manufacturing and sells these systems either directly or through distribtuion partners to hundreds of customers worldwide. Mycronic has been around for about 30 years but its modern history started when the pattern generator manufacturer Micronic acquired Mydata that manufactured systems for surface mounting. Ever since the Mydata acquisition Mycronic is divided into two business areas: Pattern Generators (PG) and Assembly Solutions (AS) where the recent acquisitions of Axxon and AEi are included in the AS segment. R&D is primarily located at the headquarter in Stockholm, Sweden. Mycronic's primary strength is its market share of 100 percent of mask writers for display applications. Consequently, every smartphone and tablet etc. has been manufactured by the help of Mycronic's technology. Our belief is that this is a niche segment that is not big enough to attract another supplier. In the AS business area Mycronic only has a share of 1-2 percent of the total surface mount technology market but within the company's niche (high mix) its market share is over 20 percent. Investments for several billion SEK have been made resulting in a large number of patents, which also in a way points to Mycronic's weakness. The technology risk forces the company to maintain its high investments to stay relevant.

+ more

Redeye Research

Reports

Notes

0.00
Today
Day High
N/A
90.25
Day Low
N/A
Day Open
88.75
Prev Close
90.25
VWAP
N/A
Volume
0K
Turnover
0.000M
Top Broker
VWAP
87.3
Avg Volume
270K
Avg Turnover
23.550M
Top Brokers
NON/CAR
VWAP
86.8
Avg Volume
299K
Avg Turnover
25.971M
Top Brokers
AVA/NON
VWAP
88.5
Avg Volume
298K
Avg Turnover
26.351M
Top Brokers
AVA/NON
52 week summary
Price Range
71.5
Last
118.3
Beta
N/A
Market Cap
8,837.0M
Total Return
-0.3%
Trailing P/E
16.8
Div Yield
2.2%
Shares Outstanding
97.9M
Next Earnings Date
7 Feb
Stock Exchange
NASDAQ Stockholm
5 day chart Go to advanced chart

Identify and measure trend strength in stocks with our Momentum tool to identify potential entry and exit signals. The tool provides a set of the most simple but powerful indicators that identify whether a stock is under sell or buy pressure.


Relative Price Strength
Change 3 Months 2.2%
Change 12 Months -10.0%
Volume Trend
Average Volume 10 vs 60 Days -32.2%
Price VS
52 Week High -23.7%
50 Day Moving Average -2.4%
200 Day moving Average 1.4%

Add article markers

Compare Mycronic to

Prev Close 0 Change 0
High 0 Avg Daily Volume 0
Low 0 Avg Daily Turnover 0
  • Management
  • Lena Olving, CEO
  • Torbjörn Wingårdh, CFO
  • Executive board
  • Patrik Tigerschiöld, Chairman of the board
Last updated: 2017-04-11 Source: Redeye
Major Owners Equity Votes
Bure Equity 29.9%
29.9%
Fjärde AP-fonden 8.7%
8.7%
Swedbank Robur Fonder 8.0%
8.0%
Handelsbanken Fonder 4.9%
4.9%
Andra AP-fonden 2.8%
2.8%
Catella Fonder 2.7%
2.7%
Avanza Pension 2.2%
2.2%
SEB Fonder 1.9%
1.9%
Vanguard 1.7%
1.7%
Dimensional Fund Advisors 1.6%
1.6%
Last updated: 2017-10-14 Source: Millistream
  •  
  • Profitability
  • ROE
  • ROCE
  • ROIC
  • EBITDA margin
  • EBIT margin
  • Net margin
  • Per share data (SEK)
  • EPS
  • EPS adj
  • Dividend
  • Net debt
  • Total shares
  • Valuation
  • EV (SEKm)
  • P/E
  • P/E diluted
  • P/Sales
  • EV/Sales
  • EV/EBITDA
  • EV/EBIT
  • P/BV
  • Capital structure
  • Equity ratio
  • Debt/equity ratio
  • Net debt(SEKm)
  • Capital employed(SEKm)
  • Capital turnover rate
  • (SEKm)
  • Net sales
  • Total operating costs
  • EBITDA
  • Depreciation
  • Amortization
  • Impairment charges
  • EBIT
  • Share in profits
  • Net financial items
  • Exchange rate dif.
  • Pre-tax profit
  • Tax
  • Net earnings
  • (SEKm)
  • Assets
  • Current assets
  • Cash in banks
  • Receivables
  • Inventories
  • Other current assets
  • Current assets
  • Fixed assets
  • Tangible assets
  • Associated comp.
  • Investments
  • Goodwill
  • Cap. exp. for dev.
  • O intangible rights
  • O non-current assets
  • Total fixed assets
  • Deferred tax assets
  • Total (assets)
  • Liabilities
  • Current liabilities
  • Short-term debt
  • Accounts payable
  • O current liabilities
  • Current liabilities
  • Long-term debt
  • O long-term liabilities
  • Convertibles
  • Total Liabilities
  • Deferred tax liab
  • Provisions
  • Shareholders' equity
  • Minority interest (BS)
  • Minority & equity
  • Total liab & SE
  • (SEKm)
  • Net sales
  • Total operating costs
  • Depreciations total
  • EBIT
  • Taxes on EBIT
  • NOPLAT
  • Depreciation
  • Gross cash flow
  • Change in WC
  • Gross CAPEX
  • Free cash flow
  • 2014
  •  
  • 22.4%
  • 23.4%
  • 39.0%
  • 18.9%
  • 18.7%
  • 18.1%
  •  
  • 2.72
  • 2.72
  • 0.00
  • -6.75
  • 97.9
  •  
  • 1,767.3
  • 9.1
  • 9.1
  • 1.6
  • 1.2
  • 6.3
  • 6.4
  • 2.0
  •  
  • 75.5%
  • 0.0%
  • -661
  • 546
  • 0.9
  • 2014
  •  
  •  
  • 661
  • 341
  • 233
  • 79
  • 1,314
  •  
  • 28
  • 0
  • 0
  • 64
  • 0
  • 65
  • 28
  • 185
  • 101
  • 1,600
  •  
  •  
  • 0
  • 76
  • 301
  • 377
  • 0
  • 5
  • 0
  • 382
  • 0
  • 11
  • 1,207
  • 0
  • 1,207
  • 1,600
  • 2014
  • 1,475
  • -1,197
  • -2
  • 276
  • -12
  • 265
  • 2
  • 267
  • 138
  • 6
  • 397
  • 2014 Q4
  • 657
  • -424
  • 233
  • -2
  • 0
  • 0
  • 231
  • 0
  • 0
  • 0
  • 231
  • 1
  • 232
  • 2015
  •  
  • 35.9%
  • 43.7%
  • 81.0%
  • 30.0%
  • 29.8%
  • 24.4%
  •  
  • 4.52
  • 4.52
  • 1.50
  • -9.04
  • 97.9
  •  
  • 7,168.5
  • 18.2
  • 18.2
  • 4.4
  • 3.9
  • 13.2
  • 13.3
  • 6.4
  •  
  • 72.1%
  • 0.2%
  • -885
  • 370
  • 1.0
  • 2015
  •  
  •  
  • 898
  • 271
  • 276
  • 55
  • 1,500
  •  
  • 38
  • 0
  • 0
  • 64
  • 0
  • 59
  • 40
  • 201
  • 41
  • 1,742
  •  
  •  
  • 12
  • 91
  • 347
  • 450
  • 0
  • 15
  • 0
  • 465
  • 0
  • 21
  • 1,256
  • 0
  • 1,256
  • 1,742
  • 2015
  • 1,815
  • -1,270
  • -4
  • 540
  • -98
  • 442
  • 4
  • 447
  • 111
  • -20
  • 618
  • 2015 Q1
  • 304
  • -275
  • 29
  • -3
  • 0
  • 0
  • 26
  • 0
  • 0
  • 0
  • 26
  • -7
  • 19
  • 2015 Q2
  • 285
  • -280
  • 4
  • -3
  • 0
  • 0
  • 1
  • 0
  • 0
  • 0
  • 1
  • -1
  • 1
  • 2015 Q3
  • 605
  • -343
  • 262
  • 0
  • 0
  • 0
  • 262
  • 0
  • 0
  • 0
  • 262
  • -34
  • 228
  • 2015 Q4
  • 621
  • -372
  • 250
  • 2
  • 0
  • 0
  • 251
  • 0
  • 0
  • 0
  • 252
  • -56
  • 195
  • 2016
  •  
  • 39.5%
  • 51.4%
  • 142.4%
  • 30.1%
  • 29.8%
  • 22.7%
  •  
  • 5.37
  • 5.37
  • 2.00
  • -2.13
  • 97.9
  •  
  • 9,387.3
  • 18.2
  • 18.2
  • 4.1
  • 4.0
  • 13.5
  • 13.6
  • 6.8
  •  
  • 51.2%
  • 0.0%
  • -209
  • 1,203
  • 0.8
  • 2016
  •  
  •  
  • 209
  • 597
  • 575
  • 151
  • 1,531
  •  
  • 60
  • 0
  • 0
  • 748
  • 293
  • 43
  • 23
  • 1,168
  • 57
  • 2,755
  •  
  •  
  • 0
  • 186
  • 823
  • 1,009
  • 0
  • 76
  • 0
  • 1,085
  • 0
  • 259
  • 1,412
  • 0
  • 1,412
  • 2,755
  • 2016
  • 2,319
  • -1,622
  • -7
  • 691
  • -163
  • 527
  • 7
  • 534
  • -149
  • -974
  • -305
  • 2016 Q1
  • 344
  • -314
  • 30
  • 1
  • 0
  • 0
  • 32
  • 0
  • 0
  • 0
  • 31
  • -8
  • 24
  • 2016 Q2
  • 463
  • -357
  • 106
  • 0
  • 0
  • 0
  • 106
  • 0
  • 0
  • 0
  • 106
  • -24
  • 82
  • 2016 Q3
  • 497
  • -345
  • 152
  • -4
  • 0
  • 0
  • 148
  • 0
  • -1
  • 0
  • 148
  • -33
  • 115
  • 2016 Q4
  • 1,016
  • -606
  • 410
  • -5
  • 0
  • 0
  • 405
  • 0
  • -1
  • 0
  • 404
  • -99
  • 306
  • 2017 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2017 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2017 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2017 Q1 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2017 Q2 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2017 Q3 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2017 Q4 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2018 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2018 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2018 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2018 Q1 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2018 Q2 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2018 Q3 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2018 Q4 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2019 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2019 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2019 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2019 Q1 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2019 Q2 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2019 Q3 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2019 Q4 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

Estimated Values is behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Last updated: 2017-10-31 Source: Redeye
Source: Redeye

Presentations, research interviews and videos from our events listed here.


Source: Redeye

When selecting comparable companies, we try to group companies that are in the same or similar sector or subsector. But, more important, have growth, margins and risk characteristics similar to the company being valued.